Near term catalysts (days/weeks/year ?).
The catalyst at this point:
Days = nothing, apart that its a biotech with good science and effective results through animal and small number of humans in advanced stage MSA.
Weeks = further results, hopefully continued improved results from the 202 study to be provided in the upcoming meetings, thus increasing interest and support/funding.
Months = completion of the trials, release of the trial results, FDA approval for Orphan drug approval, phase 3, but with a large backing.
Given the mass sell off and current SP, I too believe there has to be consolidation in the very near future. Unless somehow we get catapulted back.
Given what i believe with this drug, and a long term holder, although the catalyst in coming days will do FA, longer term catalyst will be of much greater benefit, although traders just like the quick buck and gone.
- Forums
- ASX - By Stock
- ATH
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-32
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $15.96M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $309.3K | 102.2M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
46 | 69348011 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 29671017 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
46 | 69348011 | 0.002 |
21 | 110921101 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 29671017 | 8 |
0.004 | 119608538 | 11 |
0.005 | 27994631 | 30 |
0.006 | 21743927 | 22 |
0.007 | 49369169 | 31 |
Last trade - 16.10pm 05/08/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |